Pfizer drug effective in patients with rare lung cancer

September 27, 2014 11:03 AM

15 0

Published: 27 September 2014 | Updated: 27 September 2014 7:09 PM

Pfizer Inc's Xalkori, which treats lung cancer patients with a specific gene mutation, proved effective in shrinking tumors in those with an even rarer form of the disease, according to data presented at a medical meeting. – Reuters pic, September 27, 2014.Pfizer Inc's Xalkori, which treats lung can...

Read more

To category page